Concentration Ability Impaired
7
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Neural and Cognitive Consequences of COVID-19 Survival
An Exploratory Investigation of a Supplement to Support Student Learning
Ocular Parameters in Patients With Sleep Apnea
The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology
Decline in Renal Concentration Ability in Lithium Treated Patients
Perceptions On Music And Noise In The OR
Effects of a 10 Component Dietary Supplement on Health and the Quality of Life